img

Global Drug of Abuse (DOA) Testing Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 450 | Industry : Medical Care

Publisher : GRD Survery | Format : PDF

Global Drug of Abuse (DOA) Testing Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Drug of Abuse (DOA) Testing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Drug of Abuse (DOA) Testing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Drug of Abuse (DOA) Testing market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Drug of Abuse (DOA) Testing Market Opportunities and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Drug of Abuse (DOA) Testing market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Drug of Abuse (DOA) Testing Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Drug of Abuse (DOA) Testing industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Urine
Saliva
Hair
Others

Segmented by Application
Hospitals
Laboratories
Workplace
At-Home
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Thermo Fisher Scientific
Siemens
Roche
Quest Diagnostics
Psychemedics
Merck
Bio-Rad
Abbott


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Drug of Abuse (DOA) Testing Market Status and Forecast (2016-2027)
1.3.2 Global Drug of Abuse (DOA) Testing Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Drug of Abuse (DOA) Testing Supply by Company
2.1 Global Drug of Abuse (DOA) Testing Sales Value by Company
2.2 Drug of Abuse (DOA) Testing Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Drug of Abuse (DOA) Testing Market Status by Type
3.1 Drug of Abuse (DOA) Testing Type Introduction
3.1.1 Urine
3.1.2 Saliva
3.1.3 Hair
3.1.4 Others
3.2 Global Drug of Abuse (DOA) Testing Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Drug of Abuse (DOA) Testing Market Status by Application
4.1 Drug of Abuse (DOA) Testing Segment by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Workplace
4.1.4 At-Home
4.1.5 Others
4.2 Global Drug of Abuse (DOA) Testing Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Drug of Abuse (DOA) Testing Market Status by Region
5.1 Global Drug of Abuse (DOA) Testing Market by Region
5.2 North America Drug of Abuse (DOA) Testing Market Status
5.3 Europe Drug of Abuse (DOA) Testing Market Status
5.4 Asia Pacific Drug of Abuse (DOA) Testing Market Status
5.5 Central & South America Drug of Abuse (DOA) Testing Market Status
5.6 Middle East & Africa Drug of Abuse (DOA) Testing Market Status
6 North America Drug of Abuse (DOA) Testing Market Status
6.1 North America Drug of Abuse (DOA) Testing Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Drug of Abuse (DOA) Testing Market Status
7.1 Europe Drug of Abuse (DOA) Testing Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Drug of Abuse (DOA) Testing Market Status
8.1 Asia Pacific Drug of Abuse (DOA) Testing Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Drug of Abuse (DOA) Testing Market Status
9.1 Central & South America Drug of Abuse (DOA) Testing Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Drug of Abuse (DOA) Testing Market Status
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Drug of Abuse (DOA) Testing Market Forecast by Type and by Application
12.1 Global Drug of Abuse (DOA) Testing Sales Value Forecast (2022-2027)
12.2 Global Drug of Abuse (DOA) Testing Forecast by Type
12.3 Global Drug of Abuse (DOA) Testing Forecast by Application
13 Global Drug of Abuse (DOA) Testing Market Forecast by Region/Country
13.1 Global Drug of Abuse (DOA) Testing Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Thermo Fisher Scientific
14.1.1 Company Information
14.1.2 Drug of Abuse (DOA) Testing Product Introduction
14.1.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Siemens
14.2.1 Company Information
14.2.2 Drug of Abuse (DOA) Testing Product Introduction
14.2.3 Siemens Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Roche
14.3.1 Company Information
14.3.2 Drug of Abuse (DOA) Testing Product Introduction
14.3.3 Roche Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Quest Diagnostics
14.4.1 Company Information
14.4.2 Drug of Abuse (DOA) Testing Product Introduction
14.4.3 Quest Diagnostics Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Psychemedics
14.5.1 Company Information
14.5.2 Drug of Abuse (DOA) Testing Product Introduction
14.5.3 Psychemedics Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Merck
14.6.1 Company Information
14.6.2 Drug of Abuse (DOA) Testing Product Introduction
14.6.3 Merck Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Bio-Rad
14.7.1 Company Information
14.7.2 Drug of Abuse (DOA) Testing Product Introduction
14.7.3 Bio-Rad Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Abbott
14.8.1 Company Information
14.8.2 Drug of Abuse (DOA) Testing Product Introduction
14.8.3 Abbott Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Drug of Abuse (DOA) Testing Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Drug of Abuse (DOA) Testing Sales Value (Million USD) by Company (2019-2021)
Table Global Drug of Abuse (DOA) Testing Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Drug of Abuse (DOA) Testing Sales Area
Table Drug of Abuse (DOA) Testing Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Drug of Abuse (DOA) Testing Sales Value (Million USD) by Type (2016-2021)
Table Global Drug of Abuse (DOA) Testing Sals Value Market Share by Type (2016-2021)
Table North America Drug of Abuse (DOA) Testing Sales Value (Million USD) by Type (2016-2021)
Table North America Drug of Abuse (DOA) Testing Sales Value Market Share by Type (2016-2021)
Table Europe Drug of Abuse (DOA) Testing Sales Value (Million USD) by Type (2016-2021)
Table Europe Drug of Abuse (DOA) Testing Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Value Market Share by Type (2016-2021)
Table Central & South America Drug of Abuse (DOA) Testing Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Drug of Abuse (DOA) Testing Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Drug of Abuse (DOA) Testing Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Drug of Abuse (DOA) Testing Sales Value Market Share by Type (2016-2021)
Table Global Drug of Abuse (DOA) Testing Sales Value (Million USD) by Application (2016-2021)
Table Global Drug of Abuse (DOA) Testing Value Market Share by Application (2016-2021)
Table North America Drug of Abuse (DOA) Testing Sales Value (Million USD) by Application (2016-2021)
Table North America Drug of Abuse (DOA) Testing Sales Value Market Share by Application (2016-2021)
Table Europe Drug of Abuse (DOA) Testing Sales Value (Million USD) by Application (2016-2021)
Table Europe Drug of Abuse (DOA) Testing Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Value Market Share by Application (2016-2021)
Table Central & South America Drug of Abuse (DOA) Testing Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Drug of Abuse (DOA) Testing Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Drug of Abuse (DOA) Testing Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Drug of Abuse (DOA) Testing Sales Value Market Share by Application (2016-2021)
Table Global Drug of Abuse (DOA) Testing Sales Value (Million USD) by Region (2016-2021)
Table Global Drug of Abuse (DOA) Testing Value Market Share by Region (2016-2021)
Table North America Drug of Abuse (DOA) Testing Sales Value (Million USD) by Country (2016-2021)
Table North America Drug of Abuse (DOA) Testing Value Market Share by Country (2016-2021)
Table Europe Drug of Abuse (DOA) Testing Sales Value (Million USD) by Country (2016-2021)
Table Europe Drug of Abuse (DOA) Testing Value Market Share by Country (2016-2021)
Table Asia Pacific Drug of Abuse (DOA) Testing Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Drug of Abuse (DOA) Testing Value Market Share by Country (2016-2021)
Table Central & South America Drug of Abuse (DOA) Testing Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Drug of Abuse (DOA) Testing Value Market Share by Country (2016-2021)
Table Middle East & Africa Drug of Abuse (DOA) Testing Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Drug of Abuse (DOA) Testing Value Market Share by Country (2016-2021)
Table Global Drug of Abuse (DOA) Testing Value (Million USD) Forecast by Type (2022-2027)
Table Global Drug of Abuse (DOA) Testing Value Market Share Forecast by Type (2022-2027)
Table Global Drug of Abuse (DOA) Testing Value (Million USD) Forecast by Application (2022-2027)
Table Global Drug of Abuse (DOA) Testing Value Market Share Forecast by Application (2022-2027)
Table Global Drug of Abuse (DOA) Testing Value (Million USD) Forecast by Region (2022-2027)
Table Global Drug of Abuse (DOA) Testing Value Market Share Forecast by Region (2022-2027)
Table Thermo Fisher Scientific Company Information
Table Thermo Fisher Scientific Product Introduction
Table Thermo Fisher Scientific Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Siemens Company Information
Table Siemens Product Introduction
Table Siemens Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Roche Company Information
Table Roche Product Introduction
Table Roche Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Quest Diagnostics Company Information
Table Quest Diagnostics Product Introduction
Table Quest Diagnostics Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Psychemedics Company Information
Table Psychemedics Product Introduction
Table Psychemedics Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Merck Company Information
Table Merck Product Introduction
Table Merck Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Bio-Rad Company Information
Table Bio-Rad Product Introduction
Table Bio-Rad Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)
Table Abbott Company Information
Table Abbott Product Introduction
Table Abbott Drug of Abuse (DOA) Testing Sales Value, Gross Margin and Global Share (2019-2021)